Incidental Uptake in Benign Gynecomastia on 68Ga-DOTATATE PET/CT

Veska Pandika, Matthew F. Covington

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

A 54-year-old man with mesenteric carcinoid tumor metastatic to the liver completed staging 68Ga-DOTATATE PET/CT demonstrating uptake in multiple hepatic lesions consistent with liver metastases with additional asymmetric increased uptake in the right greater than the left breast. Subsequent bilateral diagnostic mammogram revealed benign right greater than left gynecomastia without suspicious underlying mass. With Food and Drug Administration approval of 68Ga-DOTATATE and the increased use of this analog in neuroendocrine tumor imaging, this case illustrates a relevant example of uptake that can potentially mimic malignancy.

Original languageEnglish
Pages (from-to)799-800
Number of pages2
JournalClinical nuclear medicine
Volume44
Issue number10
DOIs
StatePublished - Oct 1 2019

Keywords

  • DOTATATE
  • Ga
  • gynecomastia
  • mammography
  • neuroendocrine PET

Fingerprint

Dive into the research topics of 'Incidental Uptake in Benign Gynecomastia on 68Ga-DOTATATE PET/CT'. Together they form a unique fingerprint.

Cite this